Hemagen Diagnostics Inc (HMGN)
0.00
USD |
OTCM |
May 03, 16:00
Hemagen Diagnostics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2012 | -1.413 |
| June 30, 2012 | -1.464 |
| March 31, 2012 | -1.524 |
| December 31, 2011 | -1.568 |
| September 30, 2011 | -1.756 |
| June 30, 2011 | -2.055 |
| March 31, 2011 | -1.957 |
| December 31, 2010 | -2.230 |
| September 30, 2010 | -2.408 |
| June 30, 2010 | -2.428 |
| March 31, 2010 | -2.425 |
| December 31, 2009 | -2.392 |
| September 30, 2009 | -2.514 |
| June 30, 2009 | -2.751 |
| March 31, 2009 | -2.806 |
| December 31, 2008 | -3.089 |
| September 30, 2008 | -4.229 |
| June 30, 2008 | -7.188 |
| March 31, 2008 | -6.782 |
| December 31, 2007 | -6.448 |
| September 30, 2007 | -2.862 |
| June 30, 2007 | -2.806 |
| March 31, 2007 | -3.027 |
| December 31, 2006 | -3.656 |
| September 30, 2006 | -5.426 |
| Date | Value |
|---|---|
| June 30, 2006 | -4.513 |
| March 31, 2006 | -5.108 |
| December 31, 2005 | -5.300 |
| September 30, 2005 | -4.752 |
| June 30, 2005 | -8.585 |
| March 31, 2005 | -10.33 |
| December 31, 2004 | 298.79 |
| September 30, 2004 | 14.22 |
| June 30, 2004 | 17.91 |
| March 31, 2004 | 4.019 |
| December 31, 2003 | 2.566 |
| September 30, 2003 | 1.620 |
| June 30, 2003 | 1.398 |
| March 31, 2003 | 1.066 |
| December 31, 2002 | 0.8176 |
| September 30, 2002 | 0.709 |
| June 30, 2002 | 0.5465 |
| March 31, 2002 | 0.4821 |
| December 31, 2001 | 0.4402 |
| September 30, 2001 | 0.3836 |
| June 30, 2001 | 0.3284 |
| March 31, 2001 | 0.3191 |
| December 31, 2000 | 0.2668 |
| September 30, 2000 | 0.4152 |
| June 30, 2000 | 0.2901 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |